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Introduction 
Melatonin (N-acetyl-5-methoxytryptamine), the hormone of darkness, is synthesized 
during the night by the vertebrate pineal gland. The circadian rhythm of pineal melatonin 
synthesis and release is regulated by the biological clock located, in mammals, in the 
suprachiasmatic nucleus (SCN) of the hypothalamus that project to the pineal gland via a 
multi-synaptic pathway (Reppert and Weaver, 2002). The clock rhythm is entrained to a 24 h 
period by environmental light (the photoperiod) that is directly sensed by the retina and 
conveyed to the SCN via the retino-hypothalamic tract. In humans and all other diurnal 
species, this correlates with plasma levels of melatonin that exhibit a circadian rhythm with 
high levels at night and low levels during the day. Melatonin is also produced by other tissues, 
such as the retina, the gastrointestinal tract, skin, lymphocytes and bone marrow. In mammals, 
melatonin regulates a wide-range of physiological processes including circadian and seasonal 
rhythms (seasonal breeding), hibernation, ovarian and retinal physiology, as well as immunity, 
sleep disorders, oncogenesis and depression (Pandi-Perumal et al., 2008).  
 
The melatonin receptor family   
Two mammalian high-affinity receptors for melatonin, MT1 and MT2, have been 
cloned and characterized (Reppert et al., 1994; Reppert et al., 1995). They belong to the 
superfamily of G protein-coupled receptors (GPCRs) and show high homology at the amino-
acid level (about 55% overall and 70% within transmembrane domains). A third receptor, 
Mel1c, the first melatonin receptor to be cloned from Xenopus laevis immortalized 
melanophores, was shown to be restricted to non-mammalian species including birds, chicken 
and fish (Ebisawa et al., 1994). Recently, the orphan receptor GPR50, also known as 
melatonin-related receptor, which shares 45% identity with MT1 and MT2 (Reppert et al., 
1996) was proposed to be the mammalian ortholog of Mel1c (Dufourny et al., 2008). During 
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evolution, this mammalian receptor lost its affinity for melatonin and acquired a long C-
terminal tail (C-tail). Another melatonin binding site with lower affinity, initially called MT3, 
was later characterized as the enzyme quinone reductase (QR) 2 (Zhao et al., 1997; Nosjean et 
al., 2001). Inhibition of the catalytic activity of QR2 by melatonin is suggested to participate 
in the anti-oxidant activities and protective effects of melatonin (Jockers et al., 2008). 
However, further studies are needed to better understand the relationship between MT3/QR2 
and melatonin. 
 
The G protein-mediated signal transduction pathways triggered by MT1 and MT2 
receptors have been well characterized using different mammalian cell lines expressing 
recombinant receptors or various primary cell cultures and tissues, and will not be discussed 
here. The reader is referred to two recent reviews in the field (Jockers et al., 2008; Pandi-
Perumal et al., 2008). An important discovery of the last ten years is that, in addition to G 
proteins, GPCRs, including melatonin receptors, can interact with a wide range of either 
soluble or transmembrane proteins, forming GPCR-associated protein complexes (GAPCs) 
(Daulat et al., 2009). Indeed, the nature of these GAPCs can determine its targeting to a 
specific cellular compartment, its association with other signaling or structural proteins and 
the fine-tuning of its signal transduction such as desensitization and resensitization. In 
addition, depending on the extra- and intra-cellular environment and the physiological state of 
the cell, the composition and dynamics of these GAPCs vary, thus participating in the 
dynamic regulation of GPCR function. Therefore, the identification of GAPCs constitutes an 
important step towards the development of new drugs that could be used to disrupt or 
strengthen specific interactions between GPCRs and their associated proteins. In this review, 
we will report recent results obtained in the field of GAPCs of the melatonin receptor family. 
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The reader is referred to table 1 and 2 for the identified components of MT1 and MT2 
melatonin receptor GAPCs, respectively.   
 
Proteomic approaches for the identification of GAPCs of the melatonin 
receptors 
Most identified GAPCs were discovered using the carboxy-terminal domain of GPCRs 
in yeast two-hybrid and protein micro-array assays, mainly to circumvent problems associated 
with the hydrophobic nature of full-length GPCRs. However, these efficient technologies only 
allow the discovery of proteins that directly interact with the bait. In addition, these 
approaches do not detect interactions that depend on more than one subdomain or the native 
receptor structure. To obtain an overview of the GAPCs able to directly and indirectly interact 
with the MT1 and MT2 receptors, we have developed two complementary proteomic 
approaches based on 1) the tandem affinity purification (TAP) strategy and entire receptors as 
bait (Daulat et al., 2007), and 2) peptide affinity chromatography and GPCR subdomain 
(Maurice et al., 2008).  
The TAP method, initially designed for large-scale purification of soluble protein 
complexes (Rigaut et al., 1999; Gavin et al., 2002) relies on the expression of the TAP-tagged 
target protein in the host cell. The TAP tag is composed of two affinity modules separated by 
a cleavage site for the Tobacco Etch Virus (TEV) protease leading to the recovery of the 
protein of interest and its associated protein complexes by a two-step purification protocol. In 
our study, MT1 and MT2 receptors were tagged at their C-terminus, with a TAP tag consisting 
of two immunoglobulin binding units of protein A from Staphylococcus aureus, a TEV 
cleavage site, and a calmodulin binding peptide, and expressed in human embryonic kidney 
(HEK) 293 cells (Daulat et al., 2007). The complexes were first immobilized on IgG-coated 
beads, and then specifically eluted by the addition of the TEV protease. The recovered 
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material was further bound to calmodulin-coated beads in the presence of calcium and finally 
eluted with ethylene glycol tetraacetic acid. Eluted proteins were separated by 1-dimensional 
electrophoresis and identified by mass spectrometry. With this approach, we were able to 
identify 21 and 17 proteins associated with MT1 and MT2, respectively.  
GAPCs can interact with intracellular loops, transmembrane regions and the C-tail of 
the receptor. This latter represents one of the most attractive targets for identification of 
GAPCs and in the past, much effort was focused on the identification of GAPCs binding to 
the receptor C-tail. Indeed, the sequence, length and binding motifs within this domain are 
specific to each GPCR. In addition, many splice variants of GPCRs show sequence variations 
within their C-tail, and important post-translational modifications, such as palmitoylation and 
phosphorylation, also take place within this domain. The second proteomic approach applied 
to melatonin receptors combined the use of chemically synthesized 6xHis-tagged peptides 
encompassing the entire MT1 and MT2 receptor C-tail, with immobilized metal affinity 
chromatography (IMAC) followed by 1- and 2-dimensional electrophoresis, mass 
spectrometry identification and immunoblotting to systematically identify GAPCs from 
mouse brain that interact with the C-tail of both receptors (Maurice et al., 2008). With this 
approach, 40 and 22 proteins that specifically interact with the C-tails of MT1 and MT2 
respectively were identified. 
A careful analysis of the advantages and drawbacks of both approaches shows that 
they are more complementary than mutually exclusive. The TAP-tag approach using entire 
receptors allows the purification of protein complexes formed in intact cells, under native 
conditions, and at physiological expression levels. Potential drawbacks of this approach are 
the hindrance of the TAP-tag if placed at the C-terminus (thus masking possibly the 
recruitment of GAPCs interacting with the extremity of the C-tail such as PDZ-domain 
proteins) and the restriction of the interactome due to the cell line used. Advantages of the 
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subdomain approach include the identification of GAPCs formed in a specific tissue, thus 
giving rise to the possibility of comparing GAPCs from different tissues, and under patho-
physiological conditions or after in vivo pharmacological treatments. The main limitations of 
this approach are the potential loss of the native secondary structure of the bait and the loss of 
GAPCs whose binding depends on more than one GPCR subdomain (e.g. heterotrimeric G 
proteins).  Accordingly, identified interacting partners need to be confirmed in intact cells 
using the entire GPCR to definitively eliminate the possibility of false positives.   
We will report below the GAPCs of melatonin receptors identified by these two 
proteomic strategies and their main functions in the regulation of GPCR function.  
  
GAPCs of the melatonin MT1 and MT2 receptors 
Signaling proteins 
Using the TAP strategy, we were able to identify 21 and 17 proteins associated with 
MT1 and MT2, respectively. MT1 was shown to interact with various signaling proteins such 
as the small GTPases of the Rho family Rac-1 and Rap-1A. Activation of Rap and Rac-1 
upon stimulation of various GPCRs has been already reported (Maillet et al., 2003; Pelletier et 
al., 2003; Weissman et al., 2004). Recently, Rac-1, together with beta-arrestin-1 and NADPH 
oxidase, was shown to be involved in the early phase activation of p38 MAPK mediated by β2 
adrenergic receptors (Gong et al., 2008). A role of Rac-1 in the regulation of the surface 
expression of PAR1 has also been reported (Yufu et al., 2005). Further GAPCs of MT1 are the 
2’,3’-cyclic-nucleotide 3’- phosphodiesterase and the elongation factor 1-γ. This 
phosphodiesterase belongs to the PDE3A family and is involved in the degradation of cAMP 
and cGMP, two second messengers produced following activation of melatonin receptors 
(Lugnier, 2006; Petit et al., 1999). Elongation factors have been reported to modulate GPCR 
function by direct interaction with the receptor (McClatchy et al., 2002; Cho et al., 2003).  
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A common GAPC of the MT1 and MT2 receptors was also discovered: the insulin 
receptor substrate (IRS) 4. IRS proteins are key mediators in insulin signaling and play a 
central role in maintaining basic cellular functions such as growth, survival, and metabolism 
(Sesti et al., 2001). The role of IRS4 is less well documented. Recent findings have 
demonstrated that phosphorylation of IRS4 can be mediated by PKCζ (Lee et al., 2008), a 
PKC isoform (e.g. PKCζ2) which interacts with the C-tail of both receptors (Maurice et al., 
2008), and that phosphorylation of IRS4 induced by insulin can be modulated by angiotensine 
II (Villarreal et al., 2006).  
Specific GAPCs of the MT2 receptor were also identified by the TAP approach, 
including catenin δ1 (also known as p120 catenin) and the protein phosphatase 2C (PP2C) 
isoform γ. Interestingly, catenin δ1 was also identified as specifically interacting with the C-
tail of MT2 (Maurice et al., 2008). Catenins are regulator of cadherin stability and important 
modulators of Rho GTPase activity (Reynolds, 2007). This protein was shown to interact with 
mGluR1 receptors and dissociate upon activation of the receptor by L-glutamate (Jones et al., 
2002). However, its specific role in GPCR signaling is currently unknown. The role of PP2C 
in GPCR signaling is also not well documented. PP2C has been shown to bind selectively to 
mGluR3 and to dynamically regulate the receptor by dephosphorylation of the mGluR3 C-tail 
(Flajolet et al., 2003).  
Using the subdomain approach, we were able to identify additional GAPCs that 
specifically interact with the C-tail of MT1 and MT2. Common GAPCs include casein kinase 
II (CK2) subunit α, the dual specificity phosphatase 3 and PKC ζ2. The serine/threonine 
protein kinase CK2 has been involved in phosphorylation and regulation of the M3 
muscarinic receptor by specifically coupling the GPCR to the Jun-kinase pathway (Torrecilla 
et al., 2007). Moreover, CK2 consensus sites within GPCR C-tails have been proposed to 
target GPCRs to the β-arrestin-dependent pathway (Hanyaloglu et al., 2001). More recently, 
7 
 
CK2 has been involved in RhoA phosphorylation and inhibition of arterial contractions 
induced by AT2 receptor activation (Guilluy et al., 2008). Dual specificity phosphatase 3 
(DSP3) is known to dephosphorylate protein substrates containing both phosphotyrosine and 
phosphoserine or phosphothreonine residues, with specificity for the MAPKs ERK2 and c-Jun 
NH2-terminal kinase (JNK) (Ducruet et al., 2005). PKC ζ2 is a member of the atypical PKC 
subfamily specifically expressed in the mouse brain (Hirai et al., 2003; Hirai et Chida, 2003). 
However, its role in the regulation of GPCR function remains unknown.  
Among the GAPCs that were specifically recruited by the C-tail of MT1, we identified 
two members of the ubiquitin-specific processing proteases involved in the deubiquitination 
pathway: otubain 1 and ubiquitin-specific peptidase 5 (also known as isopeptidase T). Protein 
ubiquitination is a biological process targeting proteins for degradation via the proteasome. 
Ubiquitination has another major role in the endocytosis and subsequent trafficking of plasma 
membrane proteins (Wojcikiewicz, 2004). In addition, the subunit 4 of COP9, a multiprotein 
complex of the ubiquitin-proteasome pathway, was also identified. Its role in GPCR signaling 
has not been reported so far. The β isoform of the catalytic subunit of protein phosphatase 2A 
(PPP2cb) was also identified. PP2A is a highly conserved serine/threonine phosphatase that 
plays pivotal roles in diverse cellular functions (Janssens et Goris, 2001).  PP2A has been 
shown to co-immunoprecipitate with mGluR5 and to regulate mGluR5-dependent MEK/ERK 
phosphorylation in neurons (Mao et al., 2005), and there is evidence for a direct interaction 
between PP2A and the C-tail of GPCR (Evans et al., 2008). In addition, PP2A has been 
shown to regulate H2 receptor resensitization (Fernandez et al., 2008) and myocyte 
contraction responses under β1 adrenergic receptor stimulation by limiting PKA 
phosphorylation (De Arcangelis et al., 2008). Adaptor proteins have been also identified: the 
14-3-3 proteins β et ζ and the regulator of G protein signaling 20 (also known as RGSZ1). 
The interaction between RGS20 and MT1 was recently validated by co-immunoprecipitation 
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experiments from transfected HEK293 cells and from ovine pituitary pars tuberalis 
expressing both proteins endogenously and shown to regulate the speed of MT1 signaling 
(Maurice et al., 2008). We further characterized the molecular determinants of the interaction 
and demonstrated that MT1, Gαi1 and RGS20 form a pre-associated ternary complex that 
rearranges upon agonist stimulation and where Gαi1 and RGSZ1 interact directly and 
independently with MT1 (Maurice et al., unpublished data). Finally, two additional 
candidates: the adenylate kinase isoenzyme 1 and the Rab GTPase effector Rabphilin 3A-like 
(also known as Noc2). However, their role in the regulation of GPCR function has not been 
reported. 
In contrast to the C-tail of MT1, that of MT2 appears to recruit less GAPCs. This is 
shown by the number of GAPCs identified in the TAP approach and suggests that MT1 is the 
predominant receptor that recruited a greater number of GAPCs. Two GAPCs specific for the 
MT2 C-tail were identified: the clathrin heavy chain and the tyrosine-protein phosphatase, 
non-receptor type 13 (PTPN13). PTPN13 is a member of the FERM and PSD-95/Disc-
large/Zona occludens-1 (PDZ) domain-containing PTP family. PTPN13 is a large protein that, 
in addition to a PTP domain, contains one FERM domain, five PDZ domains and a non-
catalytic C-lobe domain. Interestingly, mice that express a PTP domain-deleted form of 
PTPN13 exhibit impaired motor nerve repair and axon branching, and retinal ganglion cell 
neurite initiation and survival (Wansink et al., 2004; Lorber et al., 2005). To date, the 
participation of PTPN13 in the regulation of GPCR function has never been reported. Clathrin 
is a vesicle coat protein involved in the assembly of membrane and cargo into transport 
vesicles at the plasma membrane and on certain intracellular organelles. Many GPCRs 
internalize through the clathrin-coated vesicle endocytic pathway. The clathrin heavy chain 
has been reported to interact with the C-tail of another GPCR such as for the histamine H2 
receptor (Xu et al., 2008). Recently, clathrin has been shown to be required for 
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phosphorylation and internalization of β2 adrenergic receptors mediated by GRK2 (Mangmool 
et al., 2006). Interestingly, GRK2/3 was also identified by immunoblot screening as 
interacting proteins of both receptor C-tails (Maurice et al., 2008). The main role of GRKs is 
to recognize and phosphorylate agonist-activated GPCRs. Receptor phosphorylation triggers 
the binding of arrestins, which block the activation of G proteins, leading to rapid 
desensitization of the receptor. In addition to these phosphorylation-dependent processes, 
GRKs may also contribute in modulating cellular responses due to its ability to interact with a 
variety of proteins involved in signaling and trafficking such as Gαq and Gβγ subunits, PI3K 
or clathrin (Ribas et al., 2007).  
 
PDZ-domain proteins 
One interesting feature of the MT1 receptor is the presence of a class III recognition 
motif for PDZ domains at its C-terminal extremity (D-S-V). PDZ domains are protein 
interaction modules that are specialized for binding to C-terminal peptide motifs of proteins 
and are typically involved in the assembly of multiprotein complexes that participate in 
receptor signaling and determine binding of these complexes to membrane subdomains (e.g. 
tight junctions) (Sheng and Sala, 2001; Nourry et al., 2003). Moreover, these domains have 
been shown to represent promising targets for drug discovery (Dev, 2004). 
Using protein microarrays and quantitative fluorescence polarization, Stiffler et al. 
(Stiffler et al., 2007) characterized the binding selectivity of 157 mouse PDZ domains with 
respect to 217 genome-encoded peptides encompassing the 10 C-terminal residues of mouse 
proteins, including the MT1 receptor. By this approach, the C-terminal extremity of the MT1 
receptor was shown to interact with the channel-interacting PDZ domain protein CIPP, the 
serine protease HTRA1 and MUPP1. CIPP is composed of four PDZ domains and was 
identified as a potential partner of inward rectifier K+ family channels, N-methyl-D-aspartate 
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(NMDA) receptors, neurexins and neuroligins (Kurschner et al., 1998). In addition, CIPP has 
been shown to interact with different types of serotonin receptors and transporters (Becamel et 
al., 2004; Joubert et al., 2004; Chanrion et al., 2007) and with proteins involved in actin and 
tubulin remodeling (Alpi et al., 2009). MUPP1 is a multi-PDZ domain protein composed of 
13 PDZ domains. This protein was shown to interact with other GPCRs, including the 5-HT2C 
receptor (Becamel et al., 2001), metabotropic γ-aminobutyric acid B (GABAB) receptor 2 
(Balasubramanian et al., 2007) and recently the somatostatin receptor 3 (SSTR3) (Liew et al., 
2009). We also reported interaction between MUPP1 and MT1 using a yeast two hybrid 
screen approach with the C-tail of MT1 as bait (Guillaume et al., 2008). Interaction between 
MUPP1 and MT1 was confirmed in the ovine pituitary pars tuberalis and from mouse brain 
lysates, and shown to stabilize the MT1/Gαi complex promoting efficient Gαi-dependent 
signaling of MT1 (Guillaume et al., 2008; Maurice et al., 2008). Another PDZ domain-
containing protein described as a potential interacting candidate of the MT1 receptor was the 
neuronal NO synthase (nNOS) (Stricker et al., 1997). Using a C-terminal peptide display 
strategy, Stricker and colleagues screened 13 billion distinct C-terminal peptides to select 
sequences specific to the PDZ domain of nNOS and found that the positive peptides had a D-
X-V C-terminal consensus sequence. Searching the non-redundant protein database NCBInr 
revealed 484 matches, including the glutamate receptor 6 and the MT1 receptor. Interaction 
between nNOS and the C-tail of MT1 was confirmed in mouse brain lysates (Maurice et al., 
2008). nNOS has been sporadically shown to participate in GPCR signaling. However, since 
Stricker’s publication and to our knowledge, no additional information has been reported so 
far concerning the possibility that nNOS can directly or indirectly interact with the C-tail of 
GPCRs. Indirect recruitment of nNOS to NMDA receptors has been demonstrated through a 
PDZ/PDZ interaction with PSD-95 (Christopherson et al., 1999) and shown to significantly 
enhance NO production upon stimulation by NMDA in chinese hamster ovary (CHO) cells 
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(Ishii et al., 2006). PSD-95 is a prototypical scaffolding protein highly enriched in the 
postsynaptic density that belongs to the membrane-associated guanylate kinase family (Kim et 
Sheng, 2004).  We also reported interaction of the MT1 C-tail with PSD-95 (Maurice et al., 
2008). Interaction between PSD-95 and GPCRs has been already described as with the 
somatostatin receptors SSTR4 and SSTR1 (Christenn et al., 2007), the serotonin 5-HT2A and 
5-HT2C receptors (Becamel et al., 2002, Becamel et al., 2004), and dopamine D1 receptors 
(Zhang et al., 2007). The coupling of PSD-95 with the C-tail of GPCR has been shown to 
regulate the surface expression and intracellular trafficking of receptors and to modulate 
receptor-mediated signaling (Gavarini et al., 2006; Zhang et al., 2007).  
The MT2 receptor also contains a putative PDZ domain-binding motif at its C-terminal 
extremity (-A-D-A-L), but no PDZ domain-containing protein was identified for MT2, 
questioning the functionality of this motif.  
 
Cytoskeletal proteins 
In addition to signaling proteins, many cytoskeletal proteins were identified as GAPCs 
for melatonin receptors. Among these proteins, filamin A was identified as a common 
member of MT1- and MT2-associated complexes. Filamin A is an actin-binding protein that 
stabilizes the three-dimensional network of actin filaments, linking them to cellular 
membranes and maintains the integrity of the cell cytoskeleton. Filamin A has been reported 
to interact with several other GPCRs via either their C-tail or the third intracellular loop, 
including dopamine D2/D3 (Li et al., 2000; Lin et al., 2001), calcium-sensing (Awata et al., 
2001; Hjalm et al., 2001), mu-opoid (Onoprishvili et al., 2003), calcitonin (Seck et al., 2003), 
and more recently P2Y2 (Yu et al., 2008) receptors. Interaction between GPCR and filamin A 
has been shown to regulate receptor trafficking (Onoprishvili et al., 2003), endocytic sorting 
and recycling (Seck et al., 2003), and spreading and migration of vascular smooth muscle 
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cells (Yu et al., 2008). Other cytoskeletal proteins that interact with MT1 and MT2 receptors 
are tubulins and the glial maturation factor (GMF) β. α- and β-tubulins constitute the basic 
building block of microtubules, a major component of the cytoskeleton involved in many 
essential processes (McKean et al., 2001). α- and β-tubulins have been shown to interact with 
the C-tails of mGluR7a and mGluR1a, respectively (Ciruela et al., 1999; Saugstad et al., 
2002). By our proteomic approaches, we identified α-, β-, and γ-tubulins as GAPCs of MT1 
and MT2 receptors. We also demonstrated that microtubule dynamics modulate melatonin 
receptor function through their actions on Gαi proteins and impact on downstream signaling 
cascades (Jarzynka et al., 2006), strengthening the notion of a close interaction between 
melatonin receptors and microtubules. GMF β was identified as a growth and differentiation 
factor acting on neurons as well as glia (Lim et al., 1987) and first considered as a 
neurotrophic factor.  However, GMF was also reported as an intracellular regulator of cell 
signal transduction and notably activates p38 MAP kinases and the NF-κB transcription factor 
in astrocytes (Lim et al., 2000). Interestingly, GMF has been reported to be phosphorylated by 
PKC and CK2 (Zaheer and Lim, 1996; Zaheer and Lim, 1997), two proteins identified as 
GAPCs of both melatonin receptors. To date, interaction between GMF and GPCR has never 
been reported in the literature.  
Similar to signaling proteins, the combination of both proteomic approaches also 
showed that MT1 interacts with a greater number of cytoskeletal proteins than MT2. The 
microtubule-associated protein 2 (MAP2) was the only cytoskeletal protein identified as 
specifically recruited by the MT2 C-tail. MAP2 is a major agent responsible for promoting 
assembly and preservation of dendritic microtubules, which are the principal cytoskeletal 
constituents involved in growth and maintenance of dendrites (Dehmelt and Halpain, 2004; 
Dehmelt and Halpain, 2005). MAP2 can bind both microtubules and F-actin and changes in 
phosphorylation of MAP2 are known to affect its function. MAP2 has been reported as 
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GAPCs of mGluR5 (Farr et al., 2004) and its phosphorylation state modulated by dopamine 
D1 receptors through a PKA-associated intracellular signaling pathway (Song et al., 2002).  
In contrast, the MT1 C-tail was shown to associate with a plethora of cytoskeletal 
proteins, including actin-binding proteins from the ADF (Actin-Depolymerizing 
Factor)/cofilin family: destrin and cofilins 1 and 2. ADF/cofilin proteins are important 
regulators of actin dynamics. The binding of these proteins to F-actin, which is regulated 
negatively by phosphorylation, influences actin filament turnover. To our knowledge, the 
identification of ADF/cofilin proteins as GAPCs has never been reported. However, it was 
recently shown that cofilin is involved in the GABAA receptor trafficking by dopamine D4 
receptors (Graziane et al., 2009). Indeed, it was suggested that D4 receptor activation 
increases cofilin activity, presumably via its dephosphorylation, resulting in actin 
depolymerization and causing a decrease in the myosin-based transport of GABAA receptor 
clusters to the cell surface (Graziane et al., 2009). In addition, cofilin has been shown to 
participate in agonist-stimulated β-adrenergic receptor internalization (Volovyk et al., 2006). 
Involvement of cofilin in MT1 internalization following melatonin stimulation remains to be 
determined. Another actin-binding protein recruited by the C-tail of MT1 is the actin-related 
protein (ARP) 1 homolog B. ARP1 is part of a multiprotein complex known as dynactin, 
which is required for most, if not all, types of cytoplasmic dynein activity in eukaryotes. 
Dynactin binds dynein directly and allows the motor to traverse the microtubule lattice over 
long distances (Schroer, 2004). Other important regulators of cytoskeleton dynamics are 
microtubule-associated proteins. Whereas the C-tail of MT2 specifically associates with 
MAP2, that of MT1 interacts with another class of microtubule-associated proteins: the 
cytoplasmic linker protein 2 (CLIP2) and CLIP-associating protein 1 (or CLASP1). These 
proteins, called +TIPs for “plus-end tracking proteins”, are known to associate with the tips of 
microtubules and regulate the dynamics of microtubule (Schuyler and Pellman, 2001; Galjart, 
14 
 
2005). To date, direct interaction between +TIPs and GPCRs has never been reported. 
Another microtubule-associated protein identified as GAPC of the MT1 C-tail is kinesin. The 
kinesin superfamily proteins are motor proteins that transport membranous organelles, protein 
complexes and mRNAs to specific destinations along microtubules while hydrolyzing ATP 
for energy. Kinesins are also involved in various intracellular trafficking events such as 
axonal transport and chromosome segregation (Hirokawa and Noda, 2008). Involvement of 
kinesin in the regulation of GPCR function has never been reported. However, kinesin has 
been shown to be involved in the regulation of NMDA currents by 5-HT1A receptors in rat 
prefrontal cortex neurons (Yuen et al., 2005). The C-tail of MT1 also recruits the myosin 
heavy chain. Myosins are a large family of motor proteins responsible for actin-based 
motility. Interaction between a myosin heavy chain (IIA) and GPCR C-tail was reported for 
the chemokine CXCR4 and CCR5 receptors (Rey et al., 2002). This protein regulates 
endocytosis of CXCR4 and forms a complex with the C-tail of CXCR4 and β-arrestin (Rey et 
al., 2007). Another cytoskeletal protein known to be involved in GPCR endocytosis (Sever, 
2002) and identified as a GAPC of MT1 C-tail is dynamin. This GTPase protein regulates the 
endocytosis of numerous GPCRs following agonist activation. Finally, the MT1 C-tail also 
interacts with the glial fibrillary acidic protein (GFAP), an intermediate filament protein 
thought to be specific for astrocytes in the central nervous system. Interestingly, MT1 and 
MT2 receptors have been reported to be present in mouse astrocytes and to modulate calcium 
signaling (Peters et al., 2005), and melatonin to reduce the GFAP mRNA and protein levels in 
neural stem cells (Kong et al., 2008). Involvement of GFAP in the regulation of GPCR 
function is not known.  
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Membrane proteins and heterodimerization 
Not only soluble but also transmembrane proteins have been identified as GAPCs in 
numerous studies. Major advances have been made in the search for GPCR coupling to and 
regulation of ionic channels. Interestingly, these interactions often involve the C-tail of the 
GPCR. For instance, an interaction between the C-tail of D5 receptor and the ionotropic 
GABAA receptor has been reported (Liu et al., 2000). Similarly, the D1 receptor C-tail has 
been shown to physically interact with N-methyl-D-aspartate (NMDA) receptor (Lee et al., 
2002). Interestingly, the physical interaction between these different receptors enables the 
modulation of each receptor function. In the same manner, a direct coupling between 
nociceptin (ORL1) receptors and N-type Ca2+ channel Cav2.2 via both C-tails has been 
demonstrated and shown to mediate inhibition of N-type channel currents and internalization 
of both ORL1 and Cav2.2 upon prolonged exposure of nociceptin (Beedle et al., 2004; Altier 
et al., 2006). Finally, two recent studies have provided evidence of a direct interaction 
between the mGluR5a and NMDA receptors (Perroy et al., 2008) and between D1 receptor 
and Cav2.2 (Kisilevski et al., 2008).  
The melatonin receptors also couple to membrane proteins. Our two proteomic 
approaches identified several membrane proteins as GAPCs of MT1, including the membrane-
associated progesterone receptor component 1. This protein belongs to the membrane-
associated progesterone receptor family. The signal transduction pathways induced by binding 
of progesterone to membrane-associated progesterone receptor component 1 have not been 
described to date, although motifs for tyrosine kinase, kinase binding, SH2 and SH3 have 
been predicted from the amino acid sequence (Thomas, 2008). Another membrane protein 
that interacts with the MT1 receptor is a sodium bicarbonate cotransporter (e.g. solute carrier 
family 4, sodium bicarbonate cotransporter member 5). Sodium bicarbonate cotransporters are 
indispensable in acid-base homeostasis and could have a role in cell pH regulation (Bernardo 
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et al., 2006). A vomeronasal receptor (e.g. vomeronasal receptor 1 A12) was identified. 
Vomeronasal receptors are GPCRs that bind pheromones and are responsible for various 
behavioral and neuroendocrine responses between individuals (Rouquier et Giorgi, 2006). 
Heterodimerization between this GPCR and MT1 receptor remains to be confirmed. The MT2 
receptor was shown to interact with a Na/K-ATPase (e.g. Na/K ATPase α3 subunit). The 
Na/K-ATPase is a complex of integral membrane proteins that actively transports sodium and 
potassium across the cell plasma membrane, and maintains chemical gradients of these ions. 
In addition to pumping ions, the Na/K-ATPase has been shown to regulate the function of 
protein kinases and to act as a scaffold. Interestingly, this newly discovered signaling function 
of the Na/K-ATPase appears to play an important role in the pathogenesis of many 
cardiovascular diseases (Xie and Xie, 2005).  
Beside the potential interaction with these membrane proteins, melatonin receptors 
have been shown to form homo- and heterodimers. Indeed, the MT1 and MT2 receptors were 
among the first GPCRs, whose homo- and heterodimerization have been demonstrated by 
bioluminescence resonance energy transfer (BRET) in transfected cells (Ayoub et al., 2002). 
The propensity of MT2 homodimer formation is 3- to 4-fold lower than that of MT1/MT2 
heterodimer and MT1 homodimer formation (Ayoub et al., 2004), suggesting that MT2 may be 
preferentially engaged into heterodimers in cells co-expressing equimolar quantities of both 
receptors. Other GPCRs have also been tested for their ability to heterodimerize with 
melatonin receptors. Whereas the CCR5 chemokine, β2-adrenergic (Ayoub et al., 2002; 
Ayoub et al., 2004) and serotonin 5-HT4 (Berthouze et al., 2005) receptors do not 
heterodimerize with melatonin receptors, we demonstrated that the orphan GPR50 does 
(Levoye et al., 2006). Whereas this constitutive heterodimerization between GPR50 and MT2 
does not modify MT2 function, GPR50 completely antagonizes the function of MT1 within the 
heterodimer. Co-expression of GPR50 with MT1 dose-dependently decreases by more than 
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50% the binding of melatonin to MT1 in transfected cells. In addition, our data also 
demonstrated that MT1 is devoid of G protein coupling in the presence of GPR50, a 
phenomenon that might depend on the presence of the long C-tail of GPR50 and the 
constitutive interaction of the GPR50/MT1 heterodimer with β-arrestins (Levoye et al., 2006).  
 
Others proteins 
Other proteins belonging to chaperone or stress proteins or proteins involved in 
biosynthesis/trafficking have been identified by our proteomic approaches (table 1 and 2). It is 
interesting to note that most of the identified proteins that are involved in receptor 
biosynthesis were present in both receptor-associated complexes. This is expected because all 
GPCRs are suspected to follow the same biosynthetic pathway. However, identified proteins 
involved in trafficking clearly differ between MT1 and MT2, indicating different trafficking 
behavior. 
 
Perspectives and concluding remarks 
This review demonstrates the diversity of GAPCs that are able to interact with the 
melatonin receptor family, whose functions can be independent from or synergistic to G 
protein signaling pathways. Although the majority of these GAPCs remain to be validated 
notably in tissues expressing both proteins endogenously, this clearly increases the 
complexity of our initial view of the G protein-dependent melatonin receptor signaling. 
Moreover, it is important to note that these GAPCs are also dynamically regulated with 
respect to their molecular composition and tissue localization, thus contributing to a dynamic 
regulation of melatonin receptor function. MT1 and MT2 receptors associate clearly with a 
different repertoire of GAPCs providing additional evidence for the existence of different 
functional roles for these two receptor subtypes. According to our results, differences are 
18 
 
expected not only for receptor signaling but also for receptor trafficking, a phenomenon that is 
still poorly understood for melatonin receptors. Further investigation will be required to 
complete our view of melatonin receptor-associated protein networks and the functional role 
of its components. 
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Table 1                                                                                                           
Identified components of MT1 melatonin receptor GAPCs
Protein name Molecular mass (kDa) Identified with MT2 Approach used References
Membrane proteins
GPR50 (melatonin-related receptor) 67 + immunoprecipitation/BRET Levoye et al. , 2006
Leucine-rich repeat-containing protein 59 35 - entire receptor Daulat et al. , 2007
Membrane-associated progesterone receptor component 1 22 - entire receptor Daulat et al. , 2007
Solute carrier family 4, sodium bicarbonate cotransporter, member 5 124 - C-tail Maurice et al. , 2008
Similar to transient receptor potential cation channel, subfamily M, member 6 248 - C-tail Maurice et al. , 2008
Transmembrane protein 33 28 - entire receptor Daulat et al. , 2007
Vomeronasal receptor 1 A12 35 - C-tail Maurice et al. , 2008
Signal transduction
14-3-3 protein beta 28 - C-tail Maurice et al. , 2008
14-3-3 protein zeta 28 - C-tail Maurice et al. , 2008
2',3'-cyclic-nucleotide 3'-phosphodiesterase 48 - entire receptor Daulat et al. , 2007
Adenylate kinase isoenzyme 1 22 - C-tail Maurice et al. , 2008
Casein kinase II subunit alpha 45 + C-tail Maurice et al. , 2008
CIPP 199 - PDZ protein microarray Stiffler et al.,  2007
COP9 signalosome subunit 4 47 - C-tail Maurice et al. , 2008
Dual specificity protein phosphatase 3 20 + C-tail Maurice et al. , 2008
Elongation factor 1-gamma 50 - entire receptor Daulat et al. , 2007
GRK2/3 80 + C-tail Maurice et al. , 2008
Guanine nucleotide-binding protein beta subunit 1 37 + entire receptor Daulat et al. , 2007
Guanine nucleotide-binding protein beta subunit 4 37 + entire receptor Daulat et al. , 2007
Guanine nucleotide-binding protein Gai1 40 + entire receptor Daulat et al. , 2007
Guanine nucleotide-binding protein Gai2 40 + entire receptor Daulat et al. , 2007
Guanine nucleotide-binding protein Gai3 40 + entire receptor/C-tail Daulat et al. , 2007
Insulin receptor substrate 4 134 + entire receptor Daulat et al. , 2007
MUPP1 220 - PDZ protein microarray/C-tail Stiffler et al.,  2007
Maurice et al. , 2008
nNOS (NOS1) 155 - C-tail Maurice et al. , 2008
p21-Rac1 21 - entire receptor Daulat et al. , 2007
PKC zeta 2 47 + C-tail Maurice et al. , 2008
Protein phosphatase 2A regulatory subunits A alpha/beta 58 - C-tail Maurice et al. , 2008
Protein phosphatase 2A catalytic subunit beta isoform (Ppp2cb) 32 - C-tail Maurice et al. , 2008
PSD-95 80 - C-tail Maurice et al. , 2008
Rabphilin 3A-like (Noc2) 34 - C-tail Maurice et al. , 2008
Ras-related protein RAP-1A 21 - entire receptor Daulat et al. , 2007
Regulator of G-protein signaling 20 (RGSZ1) 27 - C-tail Maurice et al. , 2008
Ubiquitin-specific peptidase 5 (isopeptidase T) 97 - C-tail Maurice et al. , 2008
Ubiquitin thiolesterase (Otub1 protein) 31 - C-tail Maurice et al. , 2008
Cytoskeleton
Filamin A 278 + entire receptor Daulat et al. , 2007
ARP1 actin-related protein 1 homolog B 42 C-tail Maurice et al. , 2008
CLIP-associating protein 1 44 - C-tail Maurice et al. , 2008
Cofilin-1 19 - C-tail Maurice et al. , 2008
Cofilin-2 19 - C-tail Maurice et al. , 2008
Cytoplasmic linker protein 2 112 - C-tail Maurice et al. , 2008
Destrin 19 - C-tail Maurice et al. , 2008
Dynamin 85 - C-tail Maurice et al. , 2008
Dynamin 1 96 - C-tail Maurice et al. , 2008
Glial fibrillary acidic protein 47 - C-tail Maurice et al. , 2008
Glial maturation factor beta 17 + C-tail Maurice et al. , 2008
Kinesin 101 - C-tail Maurice et al. , 2008
Myosin heavy polypeptide 222 - C-tail Maurice et al. , 2008
Tubulin alpha 50 + C-tail Maurice et al. , 2008
Tubulin beta 50 + C-tail Maurice et al. , 2008
Tubulin gamma 50 + C-tail Maurice et al. , 2008
Biosynthesis
Calnexin 68 + entire receptor Daulat et al. , 2007
78-kDa glucose-regulated protein 72 + entire receptor Daulat et al. , 2007
Calreticulin 48 - entire receptor Daulat et al. , 2007
Protein-disulfide isomerase A6 48 + entire receptor Daulat et al. , 2007
Traffic, chaperone, stress response
Chaperonin subunit 5 epsilon 60 - C-tail Maurice et al. , 2008
Chaperonin subunit 2 beta 58 - C-tail Maurice et al. , 2008
DnaJ homolog, subfamily B, member 11 41 - C-tail Maurice et al. , 2008
Ras-related protein Rab-10 23 - entire receptor Daulat et al. , 2007
Vesicle-associated membrane protein associated protein B/C 27 - entire receptor Daulat et al. , 2007
Others
Brain glycogen phosphorylase 96 + C-tail Maurice et al. , 2008
Collapsin response mediator protein (CRMP) 1 62 - C-tail Maurice et al. , 2008
Dihydropyrimidinase-like 2 63 + C-tail Maurice et al. , 2008
Heterogeneous nuclear ribonucleoprotein A0 31 - entire receptor Daulat et al. , 2007
HTRA1 51 - PDZ protein microarray Stiffler et al.,  2007
Protein name Molecular mass (kDa) Identified with MT1 Approach used References
Membrane proteins
GPR50 (melatonin-related receptor) 67 + immunoprecipitation/BRET Levoye et al. , 2006
Integral membrane protein 2C 30 - entire receptor Daulat et al. , 2007
Na+/K+ ATPase alpha 3 subunit 113 - C-tail Maurice et al. , 2008
Na+/K+ ATPase 3 (fragment) 33 - C-tail Maurice et al. , 2008
Similar to WD repeat membrane protein 150 - C-tail Maurice et al. , 2008
Signal transduction
14-3-3 protein tau 28 - entire receptor Daulat et al. , 2007
Casein kinase II alpha subunit 45 + C-tail Maurice et al. , 2008
Catenin delta-1 (p120-catenin) 102 - entire receptor/C-tail Maurice et al. , 2008
Daulat et al. , 2007
Clathrin heavy polypeptide 194 - C-tail Maurice et al. , 2008
Dual specificity phosphatase 3 21 + C-tail Maurice et al. , 2008
Guanine nucleotide-binding protein beta subunit 1 37 + entire receptor Daulat et al. , 2007
Guanine nucleotide-binding protein beta subunit 4 37 + entire receptor Daulat et al. , 2007
Guanine nucleotide-binding protein Gai1 40 + entire receptor Daulat et al. , 2007
Guanine nucleotide-binding protein Gai2 40 + entire receptor Daulat et al. , 2007
Guanine nucleotide-binding protein Gai3 40 + entire receptor/C-tail Maurice et al. , 2008
Daulat et al. , 2007
Insulin receptor substrate 4 134 + entire receptor Daulat et al. , 2007
MKIAA0034 protein (clathrin heavy chain) 192 - C-tail Maurice et al. , 2008
Phosphatidylinositol 4-kinase alpha 231 - entire receptor Daulat et al. , 2007
PKC zeta 2 47 + C-tail Maurice et al. , 2008
Protein phosphatase 2C gamma isoform 59 - entire receptor Daulat et al. , 2007
Tyrosine-protein phosphatase, nonreceptor type 13 272 - C-tail Maurice et al. , 2008
Cytoskeleton
Filamin A 278 + entire receptor Daulat et al. , 2007
Glial maturation factor beta 17 + C-tail Maurice et al. , 2008
Microtubule-associated protein 2 (MAP2) 203 - C-tail Maurice et al. , 2008
Tubulin alpha 50 + C-tail Maurice et al. , 2008
Tubulin beta 50 + C-tail Maurice et al. , 2008
Tubulin gamma 50 + C-tail Maurice et al. , 2008
Biosynthesis
Calnexin 68 + entire receptor Daulat et al. , 2007
78-kDa glucose-regulated protein 72 + entire receptor Daulat et al. , 2007
Protein-disulfide isomerase A6 48 + entire receptor Daulat et al. , 2007
Traffic, chaperone, stress response
Coatomer protein complex, alpha subunit 138 + entire receptor Daulat et al. , 2007
Vacuolar sorting protein 35 92 + entire receptor Daulat et al. , 2007
Heat shock protein 9 74 - C-tail Maurice et al. , 2008
Heat shock protein 105 kDa (HSP-E7I) 96 - C-tail Maurice et al. , 2008
Table 2                                                                                                                                                                                                                                                       
Identified components of MT2 melatonin receptor GAPCs
Others
Brain glycogen phosphorylase 96 + C-tail Maurice et al. , 2008
Crystallin mu 34 - C-tail Maurice et al. , 2008
Dihydropyrimidinase-like 2 63 + C-tail Maurice et al. , 2008
Calpain 3 (mUp76) 77 - C-tail Maurice et al. , 2008
